Table 2 Characteristics of the treatment outcomes
From: Sublobar resection versus ablation for stage I non-small-cell lung cancer: a meta-analysis
Study | Groups | SR methods | Ablation | LR (%) | DR (%) | Complication (%) | Hospital stay |
|---|---|---|---|---|---|---|---|
Alexande [10] | SR | Segmental and wedge | RFA | Not given | Not given | 53.6% | Not given |
Ablation | Not given | Not given | 62.3% | Not given | |||
Ambrogi [11] | SR | Wedge | RFA | 1.7% | 11.9% | 27.1% | 6 days |
Ablation | 22.6% | 11.3% | 21.0% | 2 days | |||
Hu [12] | SR | Wedge | Microwave | 5.2% | 31.0% | Not given | Not given |
Ablation | 26.5% | 33.8% | Not given | Not given | |||
Iguchi [13] | SR | Segmental and wedge | RFA | Not given | Not given | 368 days | 16 days |
Ablation | Not given | Not given | 222 days | 6.5 days | |||
Kwan [14] | SR | Segmental and wedge | No details | Not given | Not given | 232 days | Not given |
Ablation | Not given | Not given | 110 days | Not given | |||
Safi [15] | SR | Segmental and wedge | RFA | Not given | Not given | 9.8 months | Not given |
Ablation | Not given | Not given | 5.6 months | Not given | |||
Zemlyak [16] | SR | Segmental and wedge | RFA | 12% | Not given | 0 | Not given |
Ablation | 33.3% | Not given | 66.7% | Not given | |||
Zeng [17] | SR | Wedge | No details | Not given | Not given | 194 days | Not given |
Ablation | Not given | Not given | 86 days | Not given |